Method for increasing yield of amadori rearrangement products based on inhibition mechanism of tea polyphenols and deoxyosones to degradation of amadori rearrangement products
US-2021368830-A1 · Dec 2, 2021 · US
US12336546B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12336546-B2 |
| Application number | US-202217744811-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 16, 2022 |
| Priority date | Nov 19, 2019 |
| Publication date | Jun 24, 2025 |
| Grant date | Jun 24, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure discloses an antibacterial glucose-based composite nanoparticle and a processing method and use thereof, and belongs to the technical field of processing of modern food. According to the present disclosure, the antibacterial composite nanoparticle is prepared by using a particle surface positioning modification technology and a physical field charge transfer technology with a natural glucose-based nanoparticle as a raw material. The obtained antibacterial composite nanoparticle has a particle size of 50-1,000 nm, a surface zeta potential of 0 to −10 mV and a broad-spectrum antibacterial rate of greater than 98%. The shelf life of food can be effectively prolonged to prevent spoilage of products. The antibacterial composite nanoparticle can be used in food, textiles, daily chemicals, medicine and many other fields, and has a wide application prospect.
Opening claim text (preview).
What is claimed is: 1. A method of preparing an antibacterial glucose-based composite nanoparticle, comprising the following steps: (a) dispersing a natural glucose-based nanoparticle in water, and adding a microbial GH13 family glucoside hydrolase that is 50-200 U/g of the natural glucose-based nanoparticle to conduct a catalytic reaction; (b) after the catalytic reaction is completed, adding an organic acid anhydride esterification agent and an etherification agent, adjusting the pH to 7-13 and performing a second reaction by exposure to microwave energy; and (c) after the second reaction is completed, adding a preservative of 0.01-1% by mass of the natural glucose-based nanoparticle and performing a third reaction by exposure to ultrasound, and then conducting precipitation and drying; wherein, the preservative comprises one or more selected from the group consisting of nisin, lysozyme, and chitin. 2. The method according to claim 1 , wherein, the natural glucose-based nanoparticle has a molecular weight of 10 6 -10 8 g/mol and a dispersed molecular density of 1,000-2,000 g·mol −1 ·nm −3 . 3. The method according to claim 1 , wherein, in step (a), the natural glucose-based nanoparticle in the water has a mass concentration of 10-40%. 4. The method according to claim 1 , wherein, in step (a), the catalytic reaction is carried out at a constant temperature of 30-70° C. and a pH of 3.5-7.0 for 0.5-12 h. 5. The method according to claim 1 , wherein, in step (b), the organic acid anhydride esterification agent is added in an amount of 0.5-3% of the mass of the natural glucose-based nanoparticle. 6. The method according to claim 1 , wherein, in step (b), the etherification agent is added in an amount of 1-10% of the mass of the natural glucose-based nanoparticle. 7. The method according to claim 1 , wherein, in step (c), the ultrasound is conducted at an ultrasonic frequency of 20-100 kHz; and in step (c), the third reaction is carried out at 20-50° C. for 0.1-5 h to realize charge transfer. 8. The antibacterial glucose-based composite nanoparticle prepared according to claim 1 .
Microorganisms; Enzymes · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Antimicrobial preparations · CPC title
Enzymes · CPC title
Proteins; Peptides; Derivatives or degradation products thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.